Remove Competition Remove Leads Remove Networking Remove Pharmaceutical manufacturing
article thumbnail

Call to arms as UK falls back in medicines manufacturing

pharmaphorum

Over the last 25 years, the headcount in the medicines manufacturing sector has fallen by 7,000 and since 2009 production volumes have fallen by nearly a third (29%), suggesting “faltering attractiveness” of the UK for manufacturing. ” Image from the Association of the British Pharmaceutical Industry (ABPI).

article thumbnail

The cluster effect: Connectivity and collaboration in life sciences hubs

Pharmaceutical Technology

Take Charleston, South Carolina, for example, where a growing number of medical device and pharmaceutical manufacturers, research laboratories and service companies have sprung up or settled in recent years. This August, the Charleston Chamber Foundation won a competition ran by the US Department of Commerce, which will award an $8.4m-dollar

Medical 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

What factors are driving life sciences FDI in 2022?

Pharmaceutical Technology

After all, around a third of the world’s leading life sciences corporations have their headquarters in the country. Locating a subsidiary in close proximity to such an institution has advantages beyond pipeline talent, as there is the potential to access research and tap into networks for product development and clinical trials.

article thumbnail

Using big data to stabilise pharma supply chains in an age of disruption

Pharmaceutical Technology

In an age of disruption, technology is key to enabling pharmaceutical manufacturers monitor, track and control shipments and their processes. Pharmaceutical firms are changing the way they do business; the future winners will be highly automated and digitalised.

Pharma 52